Coreline Soft Signs First Supply Agreement for Cardiovascular AI at Health Screening Center
First Application of 'AVIEW Aorta' in a Health Screening Center
Integrated Analysis of Pulmonary and Cardiovascular Risks
Enhanced Post-Examination Management and Clinical Linkage for High-Risk Groups
On July 7, Coreline Soft, a medical artificial intelligence (AI) company, announced that it will supply its AI-based cardiovascular imaging analysis solution, 'AVIEW Aorta,' to Gangnam Heart Scan, a comprehensive health screening center. This marks the first case where the product will be applied in a health screening facility.
The company explained that with this introduction, cardiovascular AI technology can expand its role from simply assisting with image interpretation to a broader range of uses in health checkups, such as risk group screening, explanation of results, post-examination management, and linkage to medical consultation.
AVIEW Aorta is software that analyzes cardiovascular images including the aorta, automatically segments the aortic region, and measures values such as diameter and volume. It enables comparison of 2D and 3D images and is integrated with Picture Archiving and Communication Systems (PACS).
Gangnam Heart Scan plans to utilize the AVIEW premium report alongside its system to establish a comprehensive chest CT-based screening and analysis framework. With a single low-dose chest CT, examinees can check not only for pulmonary nodules, emphysema, and bronchial anomalies, but also for cardiovascular risk indicators such as coronary artery calcification. Results are provided with 3D visualization to help examinees easily understand their status.
For examinees categorized as high-risk, a post-examination management team will explain the results and operate a management system that links them to consultations with in-house cardiology specialists.
In an analysis of 1,100 chest CT examinees conducted by Gangnam Heart Scan, approximately 120 patients were identified as having stage 3 or higher cardiovascular risk, requiring medication. The hospital explained that by utilizing AI-based analysis, they have established a foundation for early detection of risk signals that may have been missed with conventional screenings, enabling connection to necessary follow-up care.
This year, Gangnam Heart Scan is also considering implementing a program that combines reports on coronary artery calcification (CAC) and aorta analysis in corporate health screenings for employees of large corporations during July and August. By providing information on both pulmonary diseases and cardiovascular/aortic risks to chest CT examinees, the center aims to enhance the competitiveness of its premium health screening services.
Traditional health screenings often ended with simply delivering the results to examinees. However, for imaging tests such as chest CT, which include a wide range of clinical information, applying AI analysis and visualization technology can help examinees more easily understand their health risk levels and increase the likelihood of taking appropriate follow-up actions.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Gangnam Heart Scan representative stated, "AI is not a replacement for medical professionals' judgment, but a tool that structures risk signals and supports clinical decisions. We aim to strengthen patient-centered medical services through a system that connects screening with ongoing management."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.